Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             28 results found
no title author magazine year volume issue page(s) type
1 A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria–tetanus–pertussis vaccine Sugai, Toshiyuki
 2005
 23 46-47 p. 5450-5456
7 p.
 article
2 Aluminium phosphate potentiates the efficacy of DNA vaccines against Leishmania mexicana Rosado-Vallado, Miguel
 2005
 23 46-47 p. 5372-5379
8 p.
 article
3 A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines Oxford, J.S.
 2005
 23 46-47 p. 5440-5449
10 p.
 article
4 A reply to the Letter to the Editor by Mäkelä, Herva and Nohynek in response to the article by Rerks-Ngarm S, Treleaven SC, Chunsuttiwat S, Muangchana C, Jolley D, Brooks A, Dejsirilert S, Warintrawat S, Guiver M, Kunasol P, Maynard JE, Biggs B-A, Steinhoff M. Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. Vaccine 2004;22:975–83 Treleaven, Sophie
 2005
 23 46-47 p. 5284-5285
2 p.
 article
5 Clinical presentations of acute paralytic poliomyelitis Paul, Yash
 2005
 23 46-47 p. 5283-
1 p.
 article
6 Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model Denoël, Philippe
 2005
 23 46-47 p. 5333-5341
9 p.
 article
7 Editorial Board/Aims and Scope 2005
 23 46-47 p. CO2-
1 p.
 article
8 Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (e.g., brain heart infusion) and dairy proteins or digests (e.g., casein hydrolysates) Demain, Arnold L.
 2005
 23 46-47 p. 5420-5423
4 p.
 article
9 Enteric vaccines for pediatric use Walker, Richard I.
 2005
 23 46-47 p. 5432-5439
8 p.
 article
10 Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs Prichard, Mark N.
 2005
 23 46-47 p. 5424-5431
8 p.
 article
11 Fifth World Congress on Vaccines, Immunisation and Immunotherapy, 6 - 9 November 2006 ,Montréal, Canada 2005
 23 46-47 p. 5457-
1 p.
 article
12 Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine Wuorimaa, Tomi K
 2005
 23 46-47 p. 5328-5332
5 p.
 article
13 How increased pertussis vaccination coverage is changing the epidemiology of pertussis in Italy Rota, M. Cristina
 2005
 23 46-47 p. 5299-5305
7 p.
 article
14 Immunogenicity and immunological memory induced by a 7-valent pneumococcal CRM197 conjugate vaccine in symptomatic HIV-1 infected children Spoulou, Vana I.
 2005
 23 46-47 p. 5289-5293
5 p.
 article
15 Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis Mégret, F.
 2005
 23 46-47 p. 5342-5350
9 p.
 article
16 Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis Solomon, Anthony W.
 2005
 23 46-47 p. 5281-5282
2 p.
 article
17 Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV Zhan, Xiaoyan
 2005
 23 46-47 p. 5306-5320
15 p.
 article
18 No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study Kulkarni, P.S.
 2005
 23 46-47 p. 5286-5288
3 p.
 article
19 Pertussis antitoxin decay after vaccination with DTPa Hallander, Hans O.
 2005
 23 46-47 p. 5359-5364
6 p.
 article
20 Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein McCabe, Victoria J.
 2005
 23 46-47 p. 5380-5388
9 p.
 article
21 Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein Epstein, Suzanne L.
 2005
 23 46-47 p. 5404-5410
7 p.
 article
22 Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults Postma, Maarten J.
 2005
 23 46-47 p. 5365-5371
7 p.
 article
23 The changing epidemiology of chickenpox in Alberta Russell, M.L.
 2005
 23 46-47 p. 5398-5403
6 p.
 article
24 The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response Rivera, E.
 2005
 23 46-47 p. 5411-5419
9 p.
 article
25 The use of melatonin as a vaccine agent Regodón, Sergio
 2005
 23 46-47 p. 5321-5327
7 p.
 article
26 Uptake of varicella vaccine—a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation Marshall, Helen
 2005
 23 46-47 p. 5389-5397
9 p.
 article
27 Vaccination of newborn mice induces a strong protective immune response against respiratory and genital challenges with Chlamydia trachomatis Pal, Sukumar
 2005
 23 46-47 p. 5351-5358
8 p.
 article
28 Vaccination with recombinant tick antigens for the control of Ixodes scapularis adult infestations Almazán, Consuelo
 2005
 23 46-47 p. 5294-5298
5 p.
 article
                             28 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands